Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
98 | 4311 | 32.7 | 82% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
36 | 32479 | HUMAN PAPILLOMAVIRUS//HPV//CERVICAL INTRAEPITHELIAL NEOPLASIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HUMAN PAPILLOMAVIRUS | Author keyword | 230 | 20% | 24% | 1041 |
2 | HPV | Author keyword | 115 | 17% | 14% | 607 |
3 | CERVICAL CANCER | Author keyword | 100 | 10% | 21% | 910 |
4 | SELF SAMPLING | Author keyword | 86 | 71% | 2% | 69 |
5 | HPV GENOTYPING | Author keyword | 71 | 74% | 1% | 52 |
6 | CERVICAL INTRAEPITHELIAL NEOPLASIA | Author keyword | 66 | 20% | 7% | 293 |
7 | HPV TESTING | Author keyword | 62 | 59% | 2% | 69 |
8 | HYBRID CAPTURE | Author keyword | 61 | 61% | 2% | 66 |
9 | HUMAN PAPILLOMAVIRUS HPV | Author keyword | 42 | 25% | 3% | 146 |
10 | HYBRID CAPTURE 2 | Author keyword | 40 | 66% | 1% | 38 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HUMAN PAPILLOMAVIRUS | 230 | 20% | 24% | 1041 | Search HUMAN+PAPILLOMAVIRUS | Search HUMAN+PAPILLOMAVIRUS |
2 | HPV | 115 | 17% | 14% | 607 | Search HPV | Search HPV |
3 | CERVICAL CANCER | 100 | 10% | 21% | 910 | Search CERVICAL+CANCER | Search CERVICAL+CANCER |
4 | SELF SAMPLING | 86 | 71% | 2% | 69 | Search SELF+SAMPLING | Search SELF+SAMPLING |
5 | HPV GENOTYPING | 71 | 74% | 1% | 52 | Search HPV+GENOTYPING | Search HPV+GENOTYPING |
6 | CERVICAL INTRAEPITHELIAL NEOPLASIA | 66 | 20% | 7% | 293 | Search CERVICAL+INTRAEPITHELIAL+NEOPLASIA | Search CERVICAL+INTRAEPITHELIAL+NEOPLASIA |
7 | HPV TESTING | 62 | 59% | 2% | 69 | Search HPV+TESTING | Search HPV+TESTING |
8 | HYBRID CAPTURE | 61 | 61% | 2% | 66 | Search HYBRID+CAPTURE | Search HYBRID+CAPTURE |
9 | HUMAN PAPILLOMAVIRUS HPV | 42 | 25% | 3% | 146 | Search HUMAN+PAPILLOMAVIRUS+HPV | Search HUMAN+PAPILLOMAVIRUS+HPV |
10 | HYBRID CAPTURE 2 | 40 | 66% | 1% | 38 | Search HYBRID+CAPTURE+2 | Search HYBRID+CAPTURE+2 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ATYPICAL SQUAMOUS CELLS | 166 | 50% | 6% | 241 |
2 | HYBRID CAPTURE 2 | 159 | 84% | 2% | 86 |
3 | HYBRID CAPTURE | 134 | 72% | 2% | 106 |
4 | WORLDWIDE PERSPECTIVE | 125 | 80% | 2% | 77 |
5 | CANCER WORLDWIDE | 115 | 81% | 2% | 69 |
6 | WORLDWIDE | 113 | 22% | 10% | 446 |
7 | HPV | 111 | 25% | 9% | 393 |
8 | CYTOLOGICALLY NORMAL WOMEN | 109 | 77% | 2% | 75 |
9 | CERVICAL INTRAEPITHELIAL NEOPLASIA | 107 | 21% | 10% | 450 |
10 | LIQUID BASED CYTOLOGY | 107 | 49% | 4% | 157 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JOURNAL OF LOWER GENITAL TRACT DISEASE | 8 | 13% | 1% | 63 |
2 | INFECTIOUS AGENTS AND CANCER | 5 | 17% | 1% | 28 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer | 2012 | 173 | 126 | 56% |
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis | 2007 | 482 | 18 | 89% |
High-risk HPV testing on self-sampled versus clinician-collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening | 2013 | 42 | 50 | 92% |
Human papillomavirus and cervical cancer | 2007 | 719 | 140 | 54% |
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer | 2012 | 81 | 45 | 89% |
Human Papillomavirus Testing in the Prevention of Cervical Cancer | 2011 | 149 | 115 | 62% |
Role of E6/E7 mRNA test in the diagnostic algorithm of HPV-positive patients showing ASCUS and LSIL: clinical and economic implications in a publicly financed healthcare system | 2015 | 3 | 35 | 60% |
2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests | 2007 | 407 | 60 | 65% |
The causal relation between human papillomavirus and cervical cancer | 2002 | 1446 | 197 | 46% |
Classification of papillomaviruses | 2004 | 1296 | 49 | 27% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROYECTO EPIDEMIOL GUANACASTE | 23 | 48% | 0.8% | 35 |
2 | SCOTTISH HPV REFERENCE | 23 | 74% | 0.4% | 17 |
3 | SECT EXPT VIROL | 21 | 71% | 0.4% | 17 |
4 | AMBIOR | 15 | 88% | 0.2% | 7 |
5 | CENTRALISED CYTOL | 15 | 88% | 0.2% | 7 |
6 | HPV GRP | 12 | 38% | 0.6% | 25 |
7 | UNIT FIELD INTERVENT STUDIES | 10 | 37% | 0.5% | 22 |
8 | MASS SCREENING REGISTRY | 9 | 39% | 0.4% | 18 |
9 | SERV VIRUS ONCOGEN | 9 | 59% | 0.2% | 10 |
10 | YUAN SHAN | 9 | 52% | 0.3% | 12 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000262920 | P16INK4A//L1 CAPSID PROTEIN//PROEX C |
2 | 0.0000186634 | CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS//HIV IN WOMEN//CERVICAL DYSPLASIA |
3 | 0.0000161026 | ARIZONA PUBL HLTH//CERVICAL NEOPLASIA RISK//GENITAL HPV |
4 | 0.0000160359 | HPV VACCINE//HPV VACCINATION//HUMAN PAPILLOMAVIRUS VACCINE |
5 | 0.0000158567 | VISUAL INSPECTION WITH ACETIC ACID//CERVICOGRAPHY//SCREENING GRP |
6 | 0.0000154700 | CERVICAL SMEARS//PAPNET//PAPANICOLAOU SMEAR |
7 | 0.0000135713 | CERVICAL SCREENING//CERVICAL CANCER SCREENING//NSW CERV SCREENING PROGRAM |
8 | 0.0000113889 | CONDYLOMATA ACUMINATA//GENITAL WARTS//PENISCOPY |
9 | 0.0000107475 | CONIZATION//LLETZ//LEEP |
10 | 0.0000098949 | CELLULAR ONCOL//EMMY NOETHER GRP VIRUS ENDOCYTOSIS//PAPILLOMAVIRUS |